FibroBiologics, Inc. Common Stock (FBLG) Financials

FBLG Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 7.9 million 3.3 million
March 31, 2026 5.9 million 3.3 million
Dec. 31, 2025 9.6 million 3.5 million
Sept. 30, 2025 8.7 million 8.6 million

FBLG Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -3.3 million 707000
March 31, 2026 -4.4 million 694000
Dec. 31, 2025 -3.2 million 702000
Sept. 30, 2025 -4.0 million 704000

FBLG Net Income

No data available :(

FBLG Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 3.5 million 1.1 million -
March 31, 2026 1.5 million - 2.2 million
Dec. 31, 2025 4.9 million - 2.4 million
Sept. 30, 2025 4.9 million - 2.5 million

FBLG Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 6.3 million
March 31, 2026 3.8 million
Dec. 31, 2025 3.3 million
Sept. 30, 2025 2.2 million

FBLG Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 1.7 million 2.4 million -
March 31, 2026 - 3.0 million 2.1 million -
Dec. 31, 2025 - 797000 1.8 million -
Sept. 30, 2025 6000 2.8 million 2.2 million -

FBLG Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - -
March 31, 2026 - -
Dec. 31, 2025 - 234000
Sept. 30, 2025 - 231000

FBLG

Price: $1.44

52 week price:
0.62
12.80

Earnings Per Share: -5.29 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 5.3 million

Links: